1. Pharmacokinetics of Murine p75-Fc Fusion Protein and MP6-XT22 Anti-Murine TNF-α mAb in Mice 
Scott G. Filler, Norma V. Solis, Jane Guo, George Doellgast, Ana Ruiz-Garcia, Wei-Jian Pan 
Journal of Investigative Dermatology Symposium Proceedings 
Volume 12, Issue 1, Pages (May 2007)
DOI: /sj.jidsymp
Copyright © 2007 The Society for Investigative Dermatology, Inc Terms and Conditions

2. Figure 1
Serum concentrations of (a) the MP6-XT22 rat anti-murine TNF-α mAb and (b) the murine p75-Fc protein in mice without infection and in mice with disseminated candidiasis. (a) Mean±SEM of three mice per time point. None of the infected mice survived beyond day 7, precluding comparisons at days 14 and 21. (b) Mean±SEM of 6–7 mice per time point (*P<0.05 using t-test: statistically significant difference between infected and uninfected mice).
Journal of Investigative Dermatology Symposium Proceedings  , 52-56DOI: ( /sj.jidsymp )
Copyright © 2007 The Society for Investigative Dermatology, Inc Terms and Conditions